Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer [Yahoo! Finance]
CVRx, Inc. (CVRX)
Company Research
Source: Yahoo! Finance
for movement disorders, today announced the appointment of Nadim Yared as Chairman and Chief Executive Officer, effective immediately. Co-Founder and prior CEO Daniel Carballo will remain with the company and assume the role of VP of Strategy. Under Nadim's leadership, Encora will focus on advancing late-stage clinical programs, strengthening regulatory and reimbursement pathways, and expanding strategic partnerships to accelerate patient access. Quotes Daniel Carballo, Co-Founder and incoming VP of Strategy "Founding Encora was driven by a commitment to restore independence for movement disorder patients. I am proud of what Encora has achieved to date and grateful for the dedication of our team, investigators, and patients. Nadim brings a systems-driven approach to scaling medtech companies and a track record of aligning product development with evidence-generation and commercialization plans. I'm excited to remain deeply involved as VP of Strategy, partnering with Nadim to accel
Show less
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- CVRx to Participate at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- With 41% stake, CVRx, Inc. (NASDAQ:CVRX) seems to have captured institutional investors' interest [Yahoo! Finance]Yahoo! Finance
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $9.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
- CVRx Inc (CVRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions [Yahoo! Finance]Yahoo! Finance
CVRX
Earnings
- 11/5/25 - Beat
CVRX
Sec Filings
- 12/1/25 - Form 4
- 11/25/25 - Form 4
- 11/17/25 - Form DEL
- CVRX's page on the SEC website